Therapy of ischemic cerebral vascular disease due to atherothrombosis. (First of two parts)

J. P. Kistler, A. H. Ropper, Roberto Heros

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Preventive therapy of atherothrombotic ischemic stroke has three goals: to prevent stroke by reducing risk factors, thus preventing the pathologic process; to prevent initial or recurrent stroke by removing the underlying pathologic process - for example, by performing a carotid endarterectomy; and to ameliorate secondary brain damage by maintaining adequate perfusion to marginally ischemic areas and perhaps by reducing edema formation. Except for the elimination of risk factors, all aspects of therapy are controversial. Published proof of any given therapeutic approach is lacking; hence, current therapy is largely empirical and based on each institution's knowledge of the risks associated with its own diagnostic procedures and therapies.

Original languageEnglish
Pages (from-to)27-34
Number of pages8
JournalNew England Journal of Medicine
Volume311
Issue number1
StatePublished - Dec 1 1984
Externally publishedYes

Fingerprint

Vascular Diseases
Stroke
Pathologic Processes
Therapeutics
Carotid Endarterectomy
Edema
Perfusion
Brain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Therapy of ischemic cerebral vascular disease due to atherothrombosis. (First of two parts). / Kistler, J. P.; Ropper, A. H.; Heros, Roberto.

In: New England Journal of Medicine, Vol. 311, No. 1, 01.12.1984, p. 27-34.

Research output: Contribution to journalArticle

@article{b1b1f6557f6743ee94a1601435406eff,
title = "Therapy of ischemic cerebral vascular disease due to atherothrombosis. (First of two parts)",
abstract = "Preventive therapy of atherothrombotic ischemic stroke has three goals: to prevent stroke by reducing risk factors, thus preventing the pathologic process; to prevent initial or recurrent stroke by removing the underlying pathologic process - for example, by performing a carotid endarterectomy; and to ameliorate secondary brain damage by maintaining adequate perfusion to marginally ischemic areas and perhaps by reducing edema formation. Except for the elimination of risk factors, all aspects of therapy are controversial. Published proof of any given therapeutic approach is lacking; hence, current therapy is largely empirical and based on each institution's knowledge of the risks associated with its own diagnostic procedures and therapies.",
author = "Kistler, {J. P.} and Ropper, {A. H.} and Roberto Heros",
year = "1984",
month = "12",
day = "1",
language = "English",
volume = "311",
pages = "27--34",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "1",

}

TY - JOUR

T1 - Therapy of ischemic cerebral vascular disease due to atherothrombosis. (First of two parts)

AU - Kistler, J. P.

AU - Ropper, A. H.

AU - Heros, Roberto

PY - 1984/12/1

Y1 - 1984/12/1

N2 - Preventive therapy of atherothrombotic ischemic stroke has three goals: to prevent stroke by reducing risk factors, thus preventing the pathologic process; to prevent initial or recurrent stroke by removing the underlying pathologic process - for example, by performing a carotid endarterectomy; and to ameliorate secondary brain damage by maintaining adequate perfusion to marginally ischemic areas and perhaps by reducing edema formation. Except for the elimination of risk factors, all aspects of therapy are controversial. Published proof of any given therapeutic approach is lacking; hence, current therapy is largely empirical and based on each institution's knowledge of the risks associated with its own diagnostic procedures and therapies.

AB - Preventive therapy of atherothrombotic ischemic stroke has three goals: to prevent stroke by reducing risk factors, thus preventing the pathologic process; to prevent initial or recurrent stroke by removing the underlying pathologic process - for example, by performing a carotid endarterectomy; and to ameliorate secondary brain damage by maintaining adequate perfusion to marginally ischemic areas and perhaps by reducing edema formation. Except for the elimination of risk factors, all aspects of therapy are controversial. Published proof of any given therapeutic approach is lacking; hence, current therapy is largely empirical and based on each institution's knowledge of the risks associated with its own diagnostic procedures and therapies.

UR - http://www.scopus.com/inward/record.url?scp=0021638375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021638375&partnerID=8YFLogxK

M3 - Article

C2 - 6374458

AN - SCOPUS:0021638375

VL - 311

SP - 27

EP - 34

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 1

ER -